Royalty Pharma (RPRX)

AI Score

Unlock

32.60

0.41 (1.27%)

At close: Apr 17, 2025, 3:59 PM

32.80

0.61%

After-hours: Apr 17, 2025, 06:20 PM EDT

Royalty Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	929M	950.05M	1.76B	843M	477.01M	936.45M	2.17B	1.98B	1.71B	991.63M	2.11B	1.79B	1.54B	1.8B	1.14B	708.81M	1.01B	1.55B	2.44B	624.37M	283.68M	-1.94B
Short-Term Investments	841.97M	48.5M	38.5M	29M	18.3M	747.46M	735.01M	612.52M	717.04M	1.23B	1.29B	1.12B	1.26B	892.51M	1.51B	1.66B	983M	580M	899.12M	1.07B	509.53M	3.89B
Long-Term Investments	16.39B	228.87M	1.16B	1.1B	1.01B	14.11B	14.14B	14.41B	14.23B	15.3B	14.2B	14.39B	14.63B	14.94B	13.78B	13.47B	13.27B	13.16B	12.24B	11.57B	11.48B	n/a
Other Long-Term Assets	-476.04M	1.05B	13.91B	13.47B	14.09B	3.88M	12.83M	13.79M	15.13M	30.61M	33.41M	3.87M	4.14M	4.51M	5.96M	7.14M	28.6M	12.52M	14.72M	14.71M	87.95M	-1.94B
Receivables	26.96M	24.9M	773.68M	682.71M	775.09M	780.07M	765.14M	648.46M	727.92M	710.7M	674.59M	636.49M	682.66M	653.25M	641.69M	562.38M	626.36M	593.62M	562.39M	531.43M	491.33M	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	1.00	1.00	1.00	1.00	n/a	n/a	1.00	n/a	n/a	1.00	657.14M	599.69M	n/a	n/a	n/a	n/a
Other Current Assets	4.19M	795.64M	2.29M	5.01M	3.8M	6.78M	10.22M	4.57M	90.52M	90.52M	67.12M	5.39M	6.63M	8.95M	12.1M	6.66M	8.6M	14.4M	12.79M	52K	92K	n/a
Total Current Assets	1.8B	1.79B	2.58B	1.56B	1.27B	1.73B	2.95B	2.63B	2.55B	2.34B	3.5B	2.98B	2.88B	2.78B	2.71B	2.42B	2.7B	2.78B	3.39B	1.74B	832.07M	1.94B
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	14.97B	5.32M	n/a	1.78M	16.33M	16.58M	14.24M	14.5M	n/a	n/a	n/a	5.67M	11.47M	17.26M	23M	28.67M	34.46M	40.26M	45.99M	51.72M	n/a
Total Long-Term Assets	15.91B	16.25B	15.08B	14.57B	15.11B	14.13B	14.17B	14.44B	14.26B	15.33B	14.24B	14.4B	14.64B	14.96B	13.81B	13.5B	13.32B	13.21B	12.29B	11.63B	11.62B	-1.94B
Total Assets	18.22B	18.04B	17.66B	16.13B	16.38B	15.86B	17.12B	17.07B	16.81B	17.67B	17.74B	17.38B	17.52B	17.73B	16.51B	15.91B	21.1B	21.34B	15.69B	13.37B	12.45B	n/a
Account Payables	13.37M	22.05M	23.42M	11.55M	15.16M	13.63M	5.81M	6.66M	7.91M	16.11M	12.18M	6.66M	5.62M	9.19M	9.39M	8.27M	10.78M	24.39M	34.37M	20.75M	11.18M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-5.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	31.04M	n/a
Short-Term Debt	997.77M	996.94M	n/a	n/a	n/a	n/a	999.37M	998.44M	997.51M	996.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	182.23M	182.13M	281.98M	n/a
Other Current Liabilities	68.6M	148.76M	196.03M	100.43M	94.53M	101.71M	112.88M	98.58M	107.2M	105.73M	115.99M	116.01M	107.93M	229.13M	231.69M	218.84M	236.37M	245.59M	111.61M	110M	40.26M	n/a
Total Current Liabilities	1.25B	1.17B	275.7M	124.57M	161.38M	127.93M	1.17B	1.12B	1.17B	1.13B	182.33M	135.87M	171.25M	255.06M	283.99M	255.98M	307.89M	269.98M	450.97M	433.96M	333.42M	n/a
Long-Term Debt	6.61B	6.61B	7.6B	6.14B	6.14B	6.13B	6.13B	6.12B	6.12B	6.11B	7.11B	7.1B	7.1B	7.09B	5.83B	5.82B	5.82B	5.81B	5.73B	5.77B	5.96B	n/a
Other Long-Term Liabilities	12.08M	5.58M	27.04M	3.22M	900K	11.3M	8.5M	12.3M	2.5M	9.9M	43.7M	n/a	n/a	n/a	n/a	n/a	n/a	110M	110M	n/a	18.9M	n/a
Total Long-Term Liabilities	6.63B	6.62B	7.63B	6.14B	6.14B	6.14B	6.14B	6.14B	6.12B	6.12B	7.15B	7.1B	7.1B	7.09B	5.83B	5.82B	5.82B	5.92B	5.84B	5.77B	5.98B	n/a
Total Liabilities	7.88B	7.78B	7.9B	6.27B	6.3B	6.27B	7.31B	7.25B	7.29B	7.26B	7.33B	7.24B	7.27B	7.35B	6.11B	6.08B	6.12B	6.19B	6.29B	6.21B	6.31B	n/a
Total Debt	7.61B	7.61B	7.6B	6.14B	6.14B	6.13B	7.13B	7.12B	7.12B	7.11B	7.11B	7.1B	7.1B	7.09B	5.83B	5.82B	5.82B	5.81B	5.91B	5.96B	6.24B	n/a
Common Stock	n/a	45K	45K	45K	45K	108K	109K	108K	107K	107K	107K	106K	106K	106K	105K	102K	102K	100K	100K	2.55B	3.28B	n/a
Retained Earnings	n/a	2.76B	2.38B	2.43B	2.52B	2.13B	2.25B	2.22B	1.96B	2.5B	2.45B	2.22B	2.26B	2.32B	2.29B	1.92B	1.92B	1.81B	1.57B	2.56B	2.83B	n/a
Comprehensive Income	n/a	n/a	63K	63K	63K	63K	63K	63K	63K	16.9M	13.18M	12.3M	16.49M	20.55M	28.67M	29.45M	34.4M	34.75M	30.52M	49.21M	2.09M	4.49B
Shareholders Equity	10.34B	6.87B	6.48B	6.5B	6.53B	6.14B	6.28B	5.95B	5.63B	6.15B	6.03B	5.78B	5.78B	5.79B	5.73B	4.88B	9.9B	9.8B	4.16B	5.16B	6.11B	4.55B
Total Investments	17.23B	277.37M	1.2B	1.13B	1.03B	149.64M	147.9M	104.03M	533.94M	16.53B	15.5B	15.51B	15.89B	15.83B	15.29B	15.13B	2.1B	1.62B	1.33B	1.48B	633.59M	3.89B